Probiotics and Inflammatory Bowel Disease

Havenaar R. , Ten Brink B. Huis in ‘t Veld JHJ. In: Fuller R. , ed. Probiotics: the Scientific Basis. London: Chapman & Hall, 1992: 209–24

Holzapfel W.H. , Haberer P. , Snel J. , Schillinger U. , Huis in ‘t Veld J.H.J. Overview of gut flora and probiotics. Int J Food Microbiol 1998; 41: 85–101

Gorbach S.L. Lactic acid bacteria and human health. Ann Med 1990; 22: 37–41

Campieri M. , Gionchetti P. Probiotics in inflammatory bowel disease: new insights to pathogenesis or a possible therapeutic alternative. Gastroenterology 1999; 116: 1246–9

Russel M.G. , Stockbrügger R.W. Epidemiology of inflammatory bowel disease: an update. Scand J Gastroenterol 1996; 31: 417–27

Shivananda S. , Lennard-Jones J. , Logan R. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut 1996; 39: 690–7

Linskens R.K. , Huijsdens X.W. , Savelkoul P.H. , Vandenbroucke-Grauls C.M. , Meuwissen S.G. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl 2001; 234: 29–40

Rath H.C. , Herfarth H.H. , Ikeda J.S. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human β2 microglobulin transgenic mice. J Clin Invest 1996; 98: 945–53

Sellon R.K. , Tonkonogy S.I. , Grable H. Development of spontaneous colitis in IL-10 knock-out mice requires normal enteric bacterial flora. Gastroenterology 1997; 112: A1088

Sartor R.B. Enteric microflora in IBD: pathogens or commensal. Inflamm Bowel Dis 1997; 3: 230–5

MacDonald T.T. , Monteleone G. , Pender S.L.F. Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 2000; 51: 2–9

Van Deventer S.J.H. Immunologie in de medische praktijk. IV. Inflammatoire darmziekten; pathogenetische aanknopingspunten voor specifieke therapie. Ned T Geneesk 1997; 141: 1956–9

Janowitz H.D. , Croen E.C. , Sachar D.B. The role of the faecal stream in Crohn's disease: an historical and analytical review. Inflamm Bowel Dis 1998; 4: 29–39

Wellmann W. , Fink P.C. , Benner F. , Schmidt F.W. Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut 1986; 27: 814–20

Roediger W.E.W. , Duncan A. , Kapaniris O. , Miljard S. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 1993; 104: 802–9

Ruseler-van Embden J.G.H. , Both-Patoir H.C. Anaerobic Gram-negative faecal flora in patients with Crohn's disease and healthy subjects. Ant Leeuwenhoek 1983; 49: 125–32

Swidsinski A. , Ladhoff A. , Pernthaler A. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002; 122: 44–54

Giaffer M.H. , Holdsworth C.D. , Duerden B.I. The assessment of faecal flora in patients with inflammatory bowel diseases by a simplified bacteriological technique. J Med Microbiol 1991; 35: 238–43

Favier C. , Neut C. , Mizon C. , Cortot A. , Colombel J.F. , Mizon J. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci 1997; 42: 817–22

Sartor R.B. Review article: role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment Pharmacol Ther 1997; 11(suppl 3): 13–23

Shanahan F. Crohn's disease: seminar. Lancet 2002; 359: 62–9

Matsuda H. , Fujiyama Y. , Andoh A. , Ushijima T. , Kajinami T. , Bamba T. Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. J Gastroenterol Hepatol 2000; 15: 61–8

Fabia R. , Ar'rajab A. , Johansson M.L. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic-acid-induced colitis in the rat. Scand J Gastroenterol 1993; 28: 155–62

Pitcher M.C. , Cummings J.H. Hydrogen sulphide: a bacterial toxin in ulcerative colitis? Gut 1996; 39: 1–4

Madden M.V. , Farthing M.J.G. , Nicholls R.J. Inflammation in ideal reservoirs: pouchitis. Gut 1990; 31: 247–9

Ruseler-van Embden J.G.H. , Schouten W.R. , Lieshout van L.M.C. Pouchitis: result of microbial imbalance. Gut 1994; 35: 658–64

Salemans J.M.J.I. , Nagengast F.M. Clinical and physiological aspects of ileal pouch-anal anastomosis. Scand J Gastroenterol 1995; 30: (suppl 212): 3–12

Luukkonen P. , Valtonen V. , Sivonen A. , Sipponen P. , Jarvinen H. Fecal bacteriology and reservoir ileitis in patients operated on for ulcerative colitis. Dis Colon Rectum 1988; 31: 864–7

Schultz M. , Veltkamp C. , Dieleman L.A. Lactobacillus plantarum 299v in the treatment and prevention of spontaneous colitis in interleukin-10 deficient mice. Inflamm Bowel Dis 2002; 8: 71–80

Mao Y. , Nobaek S. , Kasravi B. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 1996; 111: 334–44

Kennedy R.J. , Hoper M. , Deodhar K. , Kirk S.J. , Gardiner K.R. Probiotic therapy fails to improve gut permeability in a hapten model of colitis. Scand J Gastroenterol 2000; 35: 1266–71

Madsen K.L. , Doyle J.S. , Jewell L.D. , Taverini M.M. , Fedorak R.N. Lactobacillus species prevents colitis in interleukin-10 gene-deficient mice. Gastroenterology 1999; 116: 1107–14

O'Mahony L. , Feeney M. , O'Halloran S. Probiotic impact on microbial flora, inflammation and tumour development in IL10 knockout mice. Aliment Pharmacol Ther 2001; 15: 1219–25

Madsen K.L. Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse. Clin Invest Med 2001; 24: 250–7

Malin M. , Suolalainen H. , Saxelin M. , Isolauri E. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab 1996; 40: 137–45

Gupta P. , Andrew H. , Kirshner B.S. Is Lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary open-label study. J Pediatr Gastroenterol Nutr 2000; 31: 453–7

Guslandi M. Maintenance treatment of Crohn's disease: role of probiotic agent. Gut 1999; 45(suppl V): A38

Guslandi M. , Mezzi G. , Sorghi M. , Testoni P.A. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 2000; 45: 1462–4

Mattila-Sandholm T. , Blum S. , Collins J.K. Probiotics: towards demonstrating efficacy. Trends Food Sci Technol 1999; 10: 393–9

Malchow H.A. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease. J Clin Gastroenterol 1997; 25: 653–8

Prantera C. , Scribano M.L. , Falasco G. , Andreoli A. , Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 2002; 51: 405–9

Bennet J.D. , Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 1989; i: 164

Kruis W. , Schutz E. , Fric P. , Fix B. , Judmaier G. , Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997; 11: 853–8

Kruis W. , Fric P. , Stolte M. Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine. Gastroenterology 2001; 120(suppl 1): A127

Rembacken B.J. , Snelling A.M. , Hawkey P.M. , Chalmers D.M. , Axon A.T. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999; 354: 635–9

Kordecki H.J. , Niedzielin K. May the enrichment of colon microflora with Lactobacillus plantarum improve the results of treatment of irritable bowel syndrome and/or ulcerative colitis? Gut 2001; 49(suppl III): 2880

Venturi A. , Gionchetti P. , Rizzelo F. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 1999; 13: 1103–8

Gionchetti P. , Rizzello F. , Venturi A. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind placebo-controlled trial. Gastroenterology 2000; 119: 305–9